Inventor
BENDER CHRISTOPHER F
US18 patents
⚠️ This page may combine multiple inventors who share the name “BENDER CHRISTOPHER F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REATA PHARMACEUTICALS INC
16 patentsUS10398711B2Sep 3, 2019
C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
REATA PHARMACEUTICALS INC15 citations94
US9889143B2Feb 13, 2018
C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
REATA PHARMACEUTICALS INC19 citations94
US9278912B2Mar 8, 2016
C13-hydroxy derivatives of oleanolic acid and methods of use thereof
REATA PHARMACEUTICALS INC30 citations94
US9556222B2Jan 31, 2017
A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
REATA PHARMACEUTICALS INC21 citations93
US9593074B2Mar 14, 2017
C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof
REATA PHARMACEUTICALS INC17 citations92
US9512094B2Dec 6, 2016
C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
REATA PHARMACEUTICALS INC22 citations92
US10501489B2Dec 10, 2019
C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof
REATA PHARMACEUTICALS INC12 citations84
US11406648B2Aug 9, 2022
C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
REATA PHARMACEUTICALS INC1 citations73
US10898499B2Jan 26, 2021
C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
REATA PHARMACEUTICALS INC2 citations73
US11292781B2Apr 5, 2022
Pyrimidine tricyclic enone derivatives for inhibition of ROR-gamma and other uses
REATA PHARMACEUTICALS INC4 citations70
US12595278B2Apr 7, 2026
Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathway
REATA PHARMACEUTICALS INC0 citations62
US11827664B2Nov 28, 2023
Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathway
REATA PHARMACEUTICALS INC1 citations62
US11059792B2Jul 13, 2021
Imidazolyl tricyclic enones as antioxidant inflammation modulators
REATA PHARMACEUTICALS INC1 citations61
US12344631B2Jul 1, 2025
C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof
REATA PHARMACEUTICALS INC0 citations59
US12195443B2Jan 14, 2025
Pyrimidine tricyclic enone derivatives for inhibition of ROR-gamma and other uses
REATA PHARMACEUTICALS INC0 citations59
US11993574B2May 28, 2024
Pyrazole and imidazole compounds for inhibition of IL-17 and RORgamma
REATA PHARMACEUTICALS INC0 citations50